Nature's Bounty

Flex-A-Min Super Glucosamine 2000 Plus

C+
N+ Score75
Joint & BoneServing: 2 Tablet(s)Type: Other Combinations [A1325]

Nature's Bounty Flex-A-Min Super Glucosamine 2000 Plus supports joint health and function. This supplement, with Glucosamine, MSM, Vitamin C, and D, aids in maintaining cartilage and bone integrity. Suitable for individuals seeking to support joint mobility and comfort.

About This Product

Flex-A-Min Super Glucosamine 2000 Plus by Nature's Bounty is a joint & bone supplement containing 10 active ingredients. It has earned an N+ Score of 75/100 (Grade C+).

This product features a fully transparent label with individual ingredient amounts disclosed, and key ingredients are present at clinically effective doses based on peer-reviewed research.

Notable clinical-dose ingredients include Vitamin C, Vitamin D, Manganese.

N+ Score Breakdown

Ingredient Adequacy83/100

Are key ingredients present at clinically effective doses based on research?

Formula Completeness25/100

Does the product include all expected ingredients for its supplement category?

Label Transparency100/100

Are individual ingredient amounts clearly disclosed without proprietary blends?

Ingredient Diversity100/100

Does the formula include a breadth of beneficial compounds from multiple pathways?

Strengths

  • +Key ingredients at clinically effective doses
  • +Fully transparent label with individual ingredient amounts disclosed
  • +Broad ingredient diversity exceeding category norms
  • +3 ingredient(s) at clinical dose levels

Weaknesses

  • −Missing several expected ingredients for its category

Ingredient Analysis (10 ingredients)

IngredientAmountDose Adequacy
Calories10.000 {Calories}N/A
Vitamin C60.000 mgAdequate
Vitamin D2000.000 IUOptimal
Manganese4.000 mgOptimal
Boron6.000 mgN/A
Total Carbohydrates2.000 gN/A
Sodium15.000 mgN/A
Methylsulfonylmethane1000.000 mgN/A
Glucosamine Hydrochloride2000.000 mgN/A
Flex Proprietary Blend36.500 mgN/A

Clinical ranges based on NIH ODS Fact Sheets and peer-reviewed research. Status indicates whether the amount meets evidence-based thresholds.